Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 25 Jun, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Recent Articles
- Samsung to Invest $648 Billion, Mostly Outside Seoul Region
- Sanjay Mehrotra's Micron Overtakes Meta, Tesla in Market Value
- Lackluster S. Korea Suffers Embarrassing 0-1 Loss to S. Africa
- China's Carmakers See Canada as 'Practice Run’ for US Sales
- China's Z.ai Closes Frontier Gap with US AI Leaders
- China Targets Solar, Wind Power Producing Half of Electricity by 2030
- US Automotive Quality Increased Industrywide Last Year
- US Consumer Inflation Topped 4.0% in May As Consumer Spending Stays Strong
- Wealthy Nations Reap Huge Benefits from Immigration, Study Finds
- Oil Back to Pre-War Levels as Hormuz Traffic Rebounds As Iran Asserts Control
